FEED · ENvue Medical, Inc. · Executive Compensation
$0.80
-0.23 (-22.33%)
At close · Sep 16
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 17, 2026
Substantial doubt about the company's ability to continue as a going concern.
“we do not have sufficient resources to fund our operations for the next twelve months from the date of this filing causing us to have substantial doubt of our ability to continue as a going concern.”View the 10-Q filed Aug 17, 2026
Market Cap
$3.09M
Shares
923,718
Volume · Sep 16
125.29K
Avg daily vol (11 sessions)
199.16K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Brian Murphy | — | $424,035 |
| Stephen Brown | — | $306,220 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Brian Murphy | — | $541,861 |
| Stephen Brown | — | $361,667 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Brian Murphy | — | $408,804 |
| Stephen Brown | — | $298,601 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Brian Murphy | — | $404,939 |
| Stephen Brown | — | $271,475 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Stephen Brown | — | $234,985 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Brian Murphy | — | $511,692 |
| Stephen Brown | — | $208,031 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Brian Murphy | — | $590,897 |
| Stephen Brown | — | $225,465 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Zeev Rotstein | Chairman of the Board | Appointed | 2026-07-14 |
| Lior Buchman | member of the Board | Appointed | 2026-07-14 |
| Zvi Joseph | member of the Board | Appointed | 2026-07-14 |
| Nino Pionati | member of the Board of Directors | Resigned | 2026-07-14 |
| David Johnson | member of the Board of Directors | Resigned | 2026-07-14 |
| David Johnson | Chairman of the Company's Board of Directors | Appointed | 2026-02-06 |
| Nicole Fernandez-McGovern | Interim Chief Financial Officer | Appointed | 2025-12-23 |
| Alison Geiger Burgett | director | Appointed | 2025-12-05 |
| Nino Pionati | director | Appointed | 2025-12-05 |
| David Johnson | director | Appointed | 2025-12-05 |
| Zeev Rotstein, M.D. | director | Appointed | 2025-12-05 |
| Doron Besser, M.D. | director | Appointed | 2025-12-05 |
| Martin Goldstein, M.D. | director | Retired | 2025-12-05 |
| Brian Murphy | director | Retired | 2025-12-05 |
| Thomas Mika | director | Retired | 2025-12-05 |
| Christopher Fashek | director | Retired | 2025-12-05 |
| Rita Silberberg | Corporate Secretary | Appointed | 2025-07-30 |
| Rita Silberberg | Executive Vice President of Finance and Chief Accounting Officer | Appointed | 2025-07-30 |
| Brian Murphy | Chief Executive Officer | Retired | 2025-06-04 |
| Doron Besser, M.D. | Chief Executive Officer | Appointed | 2025-06-04 |
| Aurora Cassirer | member of the board of directors | Resigned | 2025-04-03 |
| Michael Ferguson | director | Resigned | 2025-02-14 |
| Zeev Rotstein | director | Appointed | 2025-02-14 |
| Maria Schroeder | director | Resigned | 2025-02-14 |
| Harold Jacob | director | Resigned | 2025-02-14 |